Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 28

Discovery of unique brain tumor subtypes offers hope for targeted glioma therapies

Researchers have uncovered the mechanisms behind three unique subtypes of mismatch repair deficient high-grade gliomas. The findings provide a clearer understanding of how these tumors develop, explain why patients respond differently to immunotherapy, and are already helping guide more precise therapies.

High-grade gliomas are a group of aggressive brain tumors and one of the deadliest tumors in children and young adults. In some children, the tumors are driven by mismatch repair deficiency (MMRD), which is characterized by hypermutation (a large and quickly accumulating number of mutations in tumor cells) and resistance to standard treatments such as chemotherapy and radiation.

Tumors driven by mismatch repair deficiency are known as primary mismatch repair deficient high‑grade gliomas (priMMRD‑HGG). Because priMMRD-HGG have high numbers of mutations, treatment has shifted to immunotherapy, which uses the body’s own immune system to fight cancer by targeting cancer cells.

DNA-binding proteins from volcanic lakes could improve disease diagnosis

Scientists have uncovered new DNA-binding proteins from some of the most extreme environments on Earth and shown that they can improve rapid medical tests for infectious diseases. The work has been published in Nucleic Acids Research. The international research team, led by Durham University and working with partners in Iceland, Norway and Poland, analyzed genetic material from Icelandic volcanic lakes and deep-sea vents more than two kilometers below the surface of the North Atlantic Ocean.

Nature is the world’s largest source of useful enzymes, but many remain undiscovered. By using next-generation DNA sequencing, the researchers were able to search huge databases containing millions of potential proteins.

This approach allowed them to identify previously unknown proteins that bind to single-stranded DNA and remain stable under harsh conditions such as high temperatures, extreme pH or high salt levels.

New nanoparticles remove melanoma tumors in mice with low-power near-infrared laser

Researchers at Oregon State University have developed and tested in a mouse model a new type of nanoparticle that enables the removal of melanoma tumors with a low-power laser. After the systemically administered nanoparticles accumulate in cancerous tissue, exposure to near-infrared light causes them to heat up and destroy the melanoma cells, leaving healthy tissue unharmed.

The study led by Olena Taratula and Prem Singh of the Oregon State University College of Pharmacy represents a huge step toward solving a persistent problem with using photothermal therapy to treat melanoma, the deadliest form of skin cancer: Conventional nanoparticles require lasers with power densities that are unsafe for the skin. Findings were published in Advanced Functional Materials.

Taratula, associate professor of pharmaceutical sciences, and Singh, a postdoctoral researcher in Taratula’s lab, based their new theranostic platform —it can be used for both treatment and diagnosis—on gold nanorods. The nanorods are coated with an iron-cobalt shell and tightly loaded with a dye that heats up upon exposure to near-infrared light—invisible, low-frequency radiation able to penetrate deeply into human tissue.

Physicists Perform “Quantum Surgery” To Fix Errors While Computing

Quantum computers are often described as a glimpse of a faster, more powerful future. The catch is that today’s devices are fragile in a way ordinary computers are not. Their biggest headache is decoherence, the gradual loss of the delicate quantum behavior that makes them useful in the first place. When decoherence sets in, it can trigger two common kinds of mistakes: bit flips and phase flips.

A bit flip is the more intuitive problem. A qubit that should represent ‘0’ can unexpectedly behave like ‘1’. A phase flip is stranger but just as damaging. Even if a qubit stays in a superposition, the relationship between its components can suddenly switch, turning a positive phase into a negative one and scrambling the computation.

Why the next 25 years could surpass anything in modern memory | Peter Leyden: Full Interview

Become a Big Think member to unlock expert classes, premium print issues, exclusive events and more: https://bigthink.com/membership/?utm_…

“Old systems of the past are collapsing, and new systems of the future are still to be born. I call this moment the great progression.”

Up next, We are living through a slowdown in human progress | Jason Crawford ► • We are living through a slowdown in human…

We are at a tipping point. In the next 25 years, technologies like AI, clean energy, and bioengineering are poised to reshape society on a scale few can imagine.

Peter Leyden draws on decades of observing technological revolutions and historical patterns to show how old systems collapse, new ones rise, and humanity faces both extraordinary risk and unprecedented opportunity.

0:00 We’re on the cusp of an era of progress.

Continue reading “Why the next 25 years could surpass anything in modern memory | Peter Leyden: Full Interview” | >

Scientists Have Discovered a Protein That Reverses Brain Aging in The Lab

Our brains age along with the rest of our bodies, and as they do, they produce fewer new brain cells. Now, researchers have found a key mechanism through which the typical age-related decline in neuron production might be slowed.

In later life, the neural stem cells (NSCs) that turn into fully fledged neurons become more dormant – almost as if they’re going into retirement after a long lifetime of service. As that happens, cognitive decline creeps in.

A major reason why NSC activity fades with age is the wear and tear on telomeres, the protective caps on the ends of DNA. Telomeres fray a little more each time a cell divides, and over time, this impairs cells’ ability to grow and divide, leading to increasing cell death.

/* */